Cargando…
Growth differentiation factor‐15, treatment with liraglutide, and clinical outcomes among patients with heart failure
AIMS: Associations between growth differentiation factor‐15 (GDF‐15), cardiovascular outcomes, and exercise capacity among patients with a recent hospitalization for heart failure (HHF) and heart failure with reduced ejection fraction (HFrEF) are unknown. We utilized data from the ‘Functional Impact...
Autores principales: | Sharma, Abhinav, Greene, Stephen, Vaduganathan, Muthiah, Fudim, Marat, Ambrosy, Andrew P., Sun, Jie‐Lena, McNulty, Steven E., Hernandez, Adrian F., Borlaug, Barry A., Velazquez, Eric J., Mentz, Robert J., DeVore, Adam D., Alhanti, Brooke, Margulies, Kenneth, Felker, G. Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318489/ https://www.ncbi.nlm.nih.gov/pubmed/34061470 http://dx.doi.org/10.1002/ehf2.13348 |
Ejemplares similares
-
Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial
por: Sharma, Abhinav, et al.
Publicado: (2018) -
High‐Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network
por: Fudim, Marat, et al.
Publicado: (2018) -
Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis
por: Fudim, Marat, et al.
Publicado: (2020) -
Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018
por: Salah, Husam M., et al.
Publicado: (2022) -
Intravenous iron infusion in patients with heart failure: a systematic review and study‐level meta‐analysis
por: Salah, Husam M., et al.
Publicado: (2023)